Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant.
Andrea Phillips-BeyerAriane K KawataLeah KleinmanDalma Seboek KinterPublished in: Pharmaceutical medicine (2023)
NCT03545191 (4 June 2018).
Keyphrases
- phase iii
- clinical trial
- sleep quality
- open label
- phase ii
- double blind
- case report
- electronic health record
- depressive symptoms
- obstructive sleep apnea
- placebo controlled
- psychometric properties
- cross sectional
- big data
- study protocol
- randomized controlled trial
- physical activity
- artificial intelligence
- data analysis